Propylthiouracil Induced Rat Model Reflects Heterogeneity Observed in Clinically Non-Obese Subjects with Nonalcoholic Fatty Liver Disease
Open Access
- 7 October 2024
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (19) , 10764
Abstract
The prevalence of nonalcoholic fatty liver disease (NAFLD) is increasing, affecting up to 30% of the population, with approximately 20% of cases occurring in non-obese individuals. The recent shift to the term metabolic dysfunction-associated steatosis liver disease (MASLD) highlights the disease’s heterogeneity. However, there are no well-established animal models replicating non-obese NAFLD (NO-NAFLD). This study aimed to evaluate the relevance of the high-fat diet (HFD) combined with the propylthiouracil (PTU)-induced rat model in mimicking the histopathology and pathophysiology of NO-NAFLD. We first analyzed metabolic and clinical parameters between NO-NAFLD patients (Average BMI = 21.96 kg/m2) and obese NAFLD patients (Average BMI = 29.7 kg/m2). NO-NAFLD patients exhibited significantly higher levels of carnitines, phospholipids, and triglycerides. In the animal model, we examined serum lipid profiles, liver inflammation, histology, and transcriptomics. Hepatic steatosis in the HFD+PTU model at week 4 was comparable to that of the HFD model at week 8. The HFD+PTU model showed higher levels of carnitines, phospholipids, and triglycerides, supporting its relevance for NO-NAFLD. Additionally, the downregulation of lipid synthesis-related genes indicated differences in lipid accumulation between the two models. Overall, the HFD+PTU-induced rat model is a promising tool for studying the molecular mechanisms of NO-NAFLD.Keywords
Funding Information
- Prospective joint research project of Jiangsu Province (BY2016-078-02)
This publication has 41 references indexed in Scilit:
- Lean non-alcoholic fatty liver disease and the risk of all-cause mortality: An updated meta-analysisAnnals of Hepatology, 2024
- Comparative Burden of Metabolic Dysfunction in Lean NAFLD vs Non-lean NAFLD - A Systematic Review and Meta-analysisClinical Gastroenterology and Hepatology, 2022
- The interplay between thyroid and liver: implications for clinical practiceJournal of Endocrinological Investigation, 2020
- Mouse Models of Nonalcoholic SteatohepatitisHepatology, 2018
- Triglyceride Metabolism in the Liver2017
- Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistanceHepatology, 2017
- Animal models of non‐alcoholic fatty liver disease: current perspectives and recent advancesThe Journal of Pathology, 2016
- Prevalence of Hypothyroidism in Nonalcoholic Fatty Liver DiseaseDigestive Diseases and Sciences, 2011
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†Hepatology, 2005
- Enhancement of activities relative to fatty acid oxidation in the liver of rats depleted of l-carnitine by d-carnitine and a γ-butyrobetaine hydroxylase inhibitorBiochemical Pharmacology, 1995